Skip to content

Clinical trials

Completed Purpura, Thrombocytopenic, Idiopathic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Completed Country / region: United States Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20033
20041
20063
20076
20083
20093
20102
20111
20124
20134
20145
20151
20171
20182
20194
20204
20213
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Amgen4
Eisai Inc.4
Rigel Pharmaceuticals4
Weill Medical College of Cornell University4
Novartis Pharmaceuticals3
argenx3
Bioverativ, a Sanofi company2
Boston Children's Hospital2
Neufeld, Ellis J, MD, PhD2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic59
Thrombocytopenia9
Autoimmune Diseases4
Blood Platelet Disorders4
Hematologic Diseases4
Purpura4
Purpura, Thrombocytopenic4
Anemia, Hemolytic, Autoimmune3
Hemorrhage3
Immune System Diseases3

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.